Picture of Option Care Health logo

OPCH — Option Care Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

U.S. RESEARCH ROUNDUP- Biogen, Estee Lauder Companies, Nice

Jan 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Biogen, Estee Lauder Companies and Nice on Monday. 
    
  HIGHLIGHTS
     * Biogen Inc  BIIB.O : Canaccord Genuity raises to buy from hold
     * Estee Lauder Companies Inc  EL.N : Oppenheimer cuts to perform from outperform
     * Nice Ltd  NICE.O : JP Morgan cuts to neutral from overweight
        
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order.   
     * Air Products and Chemicals Inc  APD.N : JP Morgan raises target price to $253 from $240
     * AMC Entertainment Holdings Inc  AMC.N : Credit Suisse cuts target price to $12 from $14
     * American Campus Communities Inc  ACC.N : Evercore ISI cuts target price to $49 from $50
     * American Express Co  AXP.N : Evercore ISI raises target price to $128 from $125
     * American Express Co  AXP.N : JP Morgan raises target price to $137.50 from $134
     * American Express Co  AXP.N : RBC raises target price to $144 from $125
     * Apple Inc  AAPL.O : JP Morgan raises price target to $300 from $296
     * Avnet Inc  AVT.O : Citigroup raises price target to $42 from $40
     * Belden Inc  BDC.N : Canaccord Genuity assumes coverage with hold rating and PT of $52
     * Biogen Inc  BIIB.O : Canaccord Genuity raises price target to $360 from $305
     * Biogen Inc  BIIB.O : Canaccord Genuity raises to buy from hold
     * BorgWarner Inc  BWA.N : Jefferies cuts target price to $47 from $49
     * Byline Bancorp Inc  BY.N : Piper Sandler raises price target to $22.5 from $21.5
     * Cinemark Holdings Inc  CNK.N : Credit Suisse cuts target price to $40 from $43
     * Delphi Technologies Plc  DLPH.N : Jefferies cuts target price to $11 from $14
     * Equity Bancshares Inc  EQBK.O : D.A. Davidson cuts price target to $33 from $34
     * Equity Bancshares Inc  EQBK.O : Piper Sandler cuts price target to $32 from $35
     * Equity Lifestyle Properties Inc  ELS.N : Evercore ISI raises target price to $74 from $71
     * Estee Lauder Companies Inc  EL.N : Oppenheimer cuts to perform from outperform
     * Estee Lauder Companies Inc  EL.N : Oppenheimer cuts price target to $210 from $230
     * Evolent Health Inc  EVH.N : Canaccord Genuity raises price target to $19 from $16
     * First Financial Bancorp  FFBC.O : RBC raises target price to $26 from $24
     * First Financial Northwest Inc  FFNW.O : D.A. Davidson raises price target to $16 from $15
     * Gentex Corp  GNTX.O : Jefferies raises target price to $39 from $37
     * Hasbro Inc  HAS.O : JP Morgan initiates at rating neutral and PT $113
     * Health Insurance Innovations Inc  HIIQ.O : Canaccord Genuity cuts PT to $49 from $62
     * Hubspot Inc  HUBS.N : RBC raises target price to $215 from $190
     * IAMGOLD Corp  IAG.N : RBC cuts target price to $3.25 from $3.75
     * Intelligent Systems Corp  INS.A : BTIG starts with buy rating; price target $54
     * Lear Corp  LEA.N : Jefferies raises target price to $152 from $151
     * Matinas Biopharma Holdings  MTNB.N : Piper Sandler starts with overweight rating; $3 PT
     * Mattel Inc  MAT.O : JP Morgan initiates at rating overweight and PT $17
     * Metropolitan Bank Holding Corp  MCB.N : JP Morgan raises price target to $57 from $54
     * Nice Ltd  NICE.O : JP Morgan cuts to neutral from overweight
     * Oil States International Inc  OIS.N : Evercore ISI cuts target price to $13 from $15
     * Option Care Health Inc  BIOS.O : Canaccord Genuity raises price target to $5 from $4
     * preferred Bank  PFBC.O : Piper Sandler raises price target to $69 from $65
     * Purple Innovation Inc  PRPL.O : Keybanc raises target price to $14 from $12
     * Regency Centers Corp  REG.O : Evercore ISI cuts target price to $67 from $68
     * Relmada Therapeutics Inc  RLMD.O : Jefferies starts with buy rating; price target $75
     * Simon Property Group Inc  SPG.N : Evercore ISI raises target price to $171 from $170
     * SL Green Realty Corp  SLG.N : Evercore ISI raises target price to $100 from $99
     * SL Green Realty Corp  SLG.N : Jefferies raises target price to $98 from $94
     * South Plains Financial Inc  SPFI.O : Piper Sandler raises price target to $25 from $22
     * Sun Communities Inc  SUI.N : Evercore ISI raises target price to $158 from $155
     * Synchrony Financial  SYF.N : JP Morgan cuts target price to $35.50 from $39
     * Synchrony Financial  SYF.N : RBC cuts target price to $36 from $40
     * Synovus Financial Corp  SNV.N : Evercore ISI cuts price target to $40 from $42
     * Synovus Financial Corp  SNV.N : JP Morgan cuts price target to $40 from $43
     * Synovus Financial Corp  SNV.N : Piper Sandler cuts price target to $41 from $43
     * Synovus Financial Corp  SNV.N : SunTrust Robinson cuts price target to $42 from $48
     * Taubman Centers Inc  TCO.N : Evercore ISI cuts target price to $37 from $38
     * Teladoc Health Inc  TDOC.N : Canaccord Genuity raises price target to $116 from $95
     * Teledyne Technologies Inc  TDY.N : Jefferies raises price target to $365 from $320
     * Thor Industries  THO.N : Keybanc initiates coverage with overweight rating and PT of $95
     * Twilio Inc  TWLO.N : RBC raises target price to $140 from $125
     * Umpqua Holdings Corp  UMPQ.O : JP Morgan raises target price to $19 from $18
     * Veoneer Inc  VNE.N : Jefferies cuts target price to $15 from $19
     * Visteon Corp  VC.O : Jefferies raises target price to $95 from $90
     * Western Alliance Bancorp  WAL.N : RBC raises target price to $65 from $58
     * Winnebago Industries  WGO.N : Keybanc initiates coverage with overweight rating;PT of $67
     * Zymeworks Inc  ZYME.N : JP Morgan raises price target to $49 from $43
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Option Care Health

See all news